Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F3P2W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,830
Award facts
- Contract value 100% obligated
- $19,830.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,830.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 6, 2026, for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen per milliliter formulation. The contract, with an ultimate completion date of January 7, 2026, represents a non-set-aside competitive award under the company's existing indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. The order will support federal medical procurement needs, particularly for military and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant single-award indefinite delivery contract valued at up to $999,999,999.00 with DLA Troop Support Medical through December 31, 2031. This comprehensive pharmaceutical vehicle enables the company to supply an extensive range of medical commodities—including specialty medications, brand-name and generic drugs, vaccines, and medical supplies—to support military healthcare programs globally. The firm fixed-price structure and open competition designation demonstrate AmerisourceBergen's continued capability to fulfill critical federal medical supply requirements across therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F3P2W?
SPE2DR26F3P2W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F3P2W worth?
The government has obligated $19,830 on SPE2DR26F3P2W.
Is contract SPE2DR26F3P2W an order under another contract?
Yes. SPE2DR26F3P2W is a delivery order under SPE2DR25D3008, an indefinite delivery contract.
Was contract SPE2DR26F3P2W competed?
The extent of competition for SPE2DR26F3P2W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award